190 related articles for article (PubMed ID: 27746113)
1. DNA methylation-regulated microRNA pathways in ovarian serous cystadenocarcinoma: A meta-analysis.
Agustriawan D; Huang CH; Sheu JJ; Lee SC; Tsai JJP; Kurubanjerdjit N; Ng KL
Comput Biol Chem; 2016 Dec; 65():154-164. PubMed ID: 27746113
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic analysis of the Notch superfamily in high-grade serous ovarian cancer.
Ivan C; Hu W; Bottsford-Miller J; Zand B; Dalton HJ; Liu T; Huang J; Nick AM; Lopez-Berestein G; Coleman RL; Baggerly KA; Sood AK
Gynecol Oncol; 2013 Mar; 128(3):506-11. PubMed ID: 23200915
[TBL] [Abstract][Full Text] [Related]
3. Characterization of microRNA expression in serous ovarian carcinoma.
Li Y; Yao L; Liu F; Hong J; Chen L; Zhang B; Zhang W
Int J Mol Med; 2014 Aug; 34(2):491-8. PubMed ID: 24939816
[TBL] [Abstract][Full Text] [Related]
4. MiRNA expression signature for potentially predicting the prognosis of ovarian serous carcinoma.
Yu X; Zhang X; Bi T; Ding Y; Zhao J; Wang C; Jia T; Han D; Guo G; Wang B; Jiang J; Cui S
Tumour Biol; 2013 Dec; 34(6):3501-8. PubMed ID: 23836287
[TBL] [Abstract][Full Text] [Related]
5. A five-DNA methylation signature act as a novel prognostic biomarker in patients with ovarian serous cystadenocarcinoma.
Guo W; Zhu L; Yu M; Zhu R; Chen Q; Wang Q
Clin Epigenetics; 2018 Nov; 10(1):142. PubMed ID: 30446011
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of miR-141 and miR-200a Increase
Wahab NA; Othman Z; Nasri NWM; Mokhtar MH; Ibrahim SF; Hamid AA; Raja Ali RA; Mokhtar NM
Int J Environ Res Public Health; 2020 Apr; 17(8):. PubMed ID: 32316405
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic and genetic alterations of p33ING1b in ovarian cancer.
Shen DH; Chan KY; Khoo US; Ngan HY; Xue WC; Chiu PM; Ip P; Cheung AN
Carcinogenesis; 2005 Apr; 26(4):855-63. PubMed ID: 15677627
[TBL] [Abstract][Full Text] [Related]
8. Expression and DNA methylation alterations of seven cancer-associated 3p genes and their predicted regulator miRNAs (miR-129-2, miR-9-1) in breast and ovarian cancers.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Kazubskaya TP; Dmitriev AA; Braga EA
Gene; 2016 Jan; 576(1 Pt 3):483-91. PubMed ID: 26519551
[TBL] [Abstract][Full Text] [Related]
9. [Screening and identification of potential miRNA involved in ovarian cancer invasion and metastasis].
Liang SH; Li J; Al-beit M; Zhang J; Ma D; Lu X
Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):650-4. PubMed ID: 21122376
[TBL] [Abstract][Full Text] [Related]
10. Global methylation profiling in serous ovarian cancer is indicative for distinct aberrant DNA methylation signatures associated with tumor aggressiveness and disease progression.
Keita M; Wang ZQ; Pelletier JF; Bachvarova M; Plante M; Gregoire J; Renaud MC; Mes-Masson AM; Paquet ÉR; Bachvarov D
Gynecol Oncol; 2013 Feb; 128(2):356-63. PubMed ID: 23219462
[TBL] [Abstract][Full Text] [Related]
11. TRAIL-R3-related apoptosis: epigenetic and expression analyses in women with ovarian neoplasia.
Braga Lda C; Alvares da Silva Ramos AP; Traiman P; Silva LM; Lopes da Silva-Filho A
Gynecol Oncol; 2012 Aug; 126(2):268-73. PubMed ID: 22555108
[TBL] [Abstract][Full Text] [Related]
12. [Expression and significance of microRNAs in the p53 pathway in ovarian cancer cells and serous ovarian cancer tissues].
Zhang Q; He XJ; Ma LP; Li N; Yang J; Cheng YX; Cui H
Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):885-90. PubMed ID: 22340095
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA expression profiles in serous ovarian carcinoma.
Nam EJ; Yoon H; Kim SW; Kim H; Kim YT; Kim JH; Kim JW; Kim S
Clin Cancer Res; 2008 May; 14(9):2690-5. PubMed ID: 18451233
[TBL] [Abstract][Full Text] [Related]
15. [Methylation of some miRNA genes is involved in the regulation of their target genes RAR-beta2 and NKIRAS1 expression in lung cancer].
Khodyrev DS; Pronina IV; Rykov SV; Beresneva EV; Fridman MV; Kazubskaia TP; Loginov VI; Braga ÉA
Mol Biol (Mosk); 2012; 46(5):773-85. PubMed ID: 23156677
[TBL] [Abstract][Full Text] [Related]
16. The modularity and dynamicity of miRNA-mRNA interactions in high-grade serous ovarian carcinomas and the prognostic implication.
Zhang W; Edwards A; Fan W; Flemington EK; Zhang K
Comput Biol Chem; 2016 Aug; 63():3-14. PubMed ID: 26949157
[TBL] [Abstract][Full Text] [Related]
17. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
[TBL] [Abstract][Full Text] [Related]
18. Herpes virus microRNA expression and significance in serous ovarian cancer.
Pandya D; Mariani M; McHugh M; Andreoli M; Sieber S; He S; Dowell-Martino C; Fiedler P; Scambia G; Ferlini C
PLoS One; 2014; 9(12):e114750. PubMed ID: 25485872
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic regulation of microRNA expression in colorectal cancer.
Bandres E; Agirre X; Bitarte N; Ramirez N; Zarate R; Roman-Gomez J; Prosper F; Garcia-Foncillas J
Int J Cancer; 2009 Dec; 125(11):2737-43. PubMed ID: 19521961
[TBL] [Abstract][Full Text] [Related]
20. Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis.
Lu L; Katsaros D; de la Longrais IA; Sochirca O; Yu H
Cancer Res; 2007 Nov; 67(21):10117-22. PubMed ID: 17974952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]